Hikma Pharmaceuticals PLC (HIK)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
1,522.00p
Buy
1,524.00p
-12.00p (-0.79%)
Prices updated at 12 Dec 2025, 16:35 GMT
| Prices minimum 15 mins delay
Prices in GBX
Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
11 Nov 202511 Nov 202507 Nov 202506 Nov 202501 Oct 202523 Sep 202517 Sep 202522 Aug 202513 Aug 202507 Aug 2025
Key dates
| Forecast date | |
|---|---|
| Annual general meeting | Apr 2026 |
| Annual report | Mar 2026 |
| Final results | Feb 2026 |
| Half yearly results | - |
| Previous date | |
|---|---|
| Half yearly results | Aug 2025 |
| Annual general meeting | Apr 2025 |
| Annual report | Mar 2025 |
| Final results | Feb 2025 |
Company reports
31 Dec 2023
Annual Report 30 Jun 2025
Quarterly Report 